Rivaroxaban Tablets
10mg
Rivaroxaban 10mg tablets, used in the management of deep vein thrombosis, pulmonary embolism and stroke prevention in atrial fibrillation.
From$0.85/ tabletView
Pulmonary Embolism
A pulmonary embolism (PE) occurs when a blood clot, usually formed in a deep vein of the leg, travels to the lungs and blocks one of the pulmonary arteries. It is a medical emergency. Classic symptoms include sudden breathlessness, sharp chest pain that worsens when breathing in, a rapid heart rate, and coughing up blood. Anyone with these symptoms should seek emergency care immediately.
Key points
- A dislodged deep-vein clot blocks a pulmonary artery, bringing on sharp chest pain, sudden breathlessness and a rapid heart rate.
- Anticoagulant treatment stops the clot enlarging and remains central to care from the emergency phase through follow-up recovery.
- Newer oral anticoagulants, including rivaroxaban, avoid routine blood monitoring and have replaced older agents in much of current practice.
Anticoagulation: the core of PE treatment
Stopping the clot from growing and preventing new ones is the immediate priority. Anticoagulant medicines are the backbone of PE management, used both in hospital and during the weeks of recovery that follow. Direct oral anticoagulants have largely replaced older agents in many countries because they do not require routine blood-test monitoring. Rivaroxaban is one such agent, approved for the treatment of PE and for reducing the risk of recurrence. Treatment duration depends on whether the clot had an identifiable trigger or arose spontaneously; longer courses are used when the underlying risk persists. People with heart and blood pressure conditions may have additional considerations that affect which anticoagulant is chosen and for how long.